ScholarIQanswers from OpenAlex

A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma

PaperCitations, authors & open-access status

A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma have?

ScholarIQcitation count

A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma has 25 citations in the OpenAlex counts ScholarIQ stores.

When was A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma published?

ScholarIQyear

A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma has 2022 year in the ScholarIQ index.

What is the open-access status of A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma?

ScholarIQoa status

A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma has diamond oa status in the ScholarIQ index.

What is the DOI of A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma?

ScholarIQdoi

The DOI for A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma is on the source record.

What is the OpenAlex record for A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma?

ScholarIQopenalex

The OpenAlex for A narrative review of the role of common EGFR mutations in pathogenesis and treatment of non-small-cell lung carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial